Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LTX-109 for Nasal Decolonisation of Staphylococcus Aureus
NCT04767321Phase 2Completed
- Sponsor
- Pharma
- Start
- Feb 2021
- Primary completion
- Mar 2021
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of voxvoganan in Staphylococcus aureus carriage, sponsored by Pharma. Started Feb 2021; status: completed.
02
Drugs
voxvoganan
03
Conditions
Staphylococcus aureus carriage
Beyond the preview
Go deeper on NCT04767321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04767321.